4-(((1R,4r)-4-(3-(4-(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid

Catalog No.: 
ACTDMS555
CAS No.: 
948304-40-3
Molecular Formula: 
C21H21F3N2O5
Molecular Weight: 
438.40
4-(((1R,4r)-4-(3-(4-(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$81.00InquiryInquiry
10mg95%$131.00InquiryInquiry
25mg95%$275.00InquiryInquiry
50mg95%$445.00InquiryInquiry
100mg95%$740.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(((1R,4r)-4-(3-(4-(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid
IUPAC Name4-(((1r,4r)-4-(3-(4-(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoic acid
Molecular FormulaC21H21F3N2O5
Molecular Weight438.40
SMILESO=C(NC1=CC=C(OC(F)(F)F)C=C1)N[C@H]1CC[C@H](OC2=CC=C(C(=O)O)C=C2)CC1
InChI KeyXDVFKCZZXOGEMN-CZIWCDLHSA-N
SynonymUC-1728 (Synonyms: t-TUCB);UC-1728 (t-TUCB);UC-1728;t-TUCB.;UC-1728; UC 1728; UC1728; T-TUCB.;Benzoic acid, 4-[[trans-4-[[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]amino]cyclohexyl]oxy]-;t-TUCB UC-1728;UC-1728,Inhibitor,UC1728,Epoxide Hydrolase,UC 1728,inhibit
CAS No.948304-40-3

Synthetic Route by SureRoute

1. ACTDMS555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDMS555 route product structure diagram
    ACTDMS555948304-40-3
Inquiry

2. ACTDMS555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDMS555 route product structure diagram
    ACTDMS555948304-40-3
Inquiry

3. ACTDMS555 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDMS555 route product structure diagram
    ACTDMS555948304-40-3
Inquiry

Comments (0)